Insider · CIK 0001741968

Degnan Chris

Reports to the SEC for 3 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001741968

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,483 sh	—	—	6,763
2026-10-08	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,483 sh	—	—	4,484
2026-10-08	URGNUroGen Pharma Ltd.S Sale	Chief Financial Officer	SSale	−2,202 sh	$36.69	−$80.8K	4,561
2026-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+32.6K sh	—	—	32,609
2025-10-08	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,483 sh	—	—	8,967
2025-10-08	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,483 sh	—	—	4,483
2025-10-08	URGNUroGen Pharma Ltd.S Sale	Chief Financial Officer	SSale	−2,203 sh	$16.85	−$37.1K	2,280
2024-10-08	URGNUroGen Pharma Ltd. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+74.1K sh	—	—	74,142
2024-10-08	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+13.5K sh	—	—	13,450
2023-03-13	GRTXGalera Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.96	+$19.6K	10,000
2023-02-25	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+185K sh	—	—	185,000
2022-02-28	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+135K sh	—	—	135,000
2021-01-26	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.5K sh	—	—	82,500
2020-01-31	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+74.4K sh	—	—	74,435
2019-11-06	GRTXGalera Therapeutics, Inc. · Stock OptionA Award	Chief Financial Officer	AAward	+230K sh	—	—	229,513
2019-02-28	VRCAVerrica Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+44K sh	—	—	44,000
2018-06-19	VRCAVerrica Pharmaceuticals Inc.P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$15.00	+$45K	3,000

Recent filings

Accepted (ET)
Oct 9 12:574
Degnan Chris0001437749-26-032421
SEC(opens sec.gov)
Feb 34
Degnan Chris0001437749-26-002841
SEC(opens sec.gov)
Oct 94
Degnan Chris0001437749-25-030772
SEC(opens sec.gov)
Oct 94
Degnan Chris0001415889-24-024932
SEC(opens sec.gov)
Mar 144
Degnan Chris0000899243-23-008288
SEC(opens sec.gov)
Feb 284
Degnan Chris0000899243-23-006470
SEC(opens sec.gov)
Mar 24
Degnan Chris0000899243-22-008583
SEC(opens sec.gov)
Jan 284
Degnan Chris0000899243-21-003614
SEC(opens sec.gov)
Feb 44
Degnan Chris0000899243-20-002869
SEC(opens sec.gov)
Nov 84
Degnan Chris0000899243-19-027034
SEC(opens sec.gov)
Mar 44
Degnan Chris0001209191-19-015811
SEC(opens sec.gov)
Aug 154
Degnan Chris0001209191-18-046825
SEC(opens sec.gov)

Companies

Address

400 ALEXANDER PARK DRIVE

PRINCETON, NJ, 08540